CFAH CORE TECHNOLOGIES – VHIO – Vall d'Hebron Institute of Oncology


VHIO: Working together to advance personalized and targeted therapies against cancer

VHIO´s Molecular Pathology, Cancer Genomics, Proteomics, and Translational Genomics groups, led by Paolo G. Nuciforo, Ana Vivancos, Francesc Canals and Aleix Prat respectively, are central to all our activities. Not only do they provide and develop state-of-the-art technologies for all research programs and groups at VHIO, but also function as key research groups pursuing independent research projects.